αž αž·αžšαž‰αŸ’αž‰αžœαžαŸ’αžαž»
αž αž·αžšαž‰αŸ’αž‰αžœαžαŸ’αžαž»
αž‘αžΈαž•αŸ’αžŸαžΆαžš
Takeda Pharmaceutical Co Ltd
31.12$
2 αž€αž»αž˜αŸ’αž—αŸˆ, 5:20:00 PM αž˜αŸ‰αŸ„αž„β€‹αžŸαž€αž› -5 · USD · OTCMKTS · αžŸαŸαž…αž€αŸ’αžŠαžΈαž”αŸ’αžšαž€αžΆαžŸαž˜αž·αž“αž‘αž‘αž½αž›αžαž»αžŸαžαŸ’αžšαžΌαžœ
αž—αžΆαž‚β€‹αž αŸŠαž»αž“αž˜αžΌαž›αž”αžαŸ’αžšαžŠαŸ‚αž›αž”αžΆαž“αž…αž»αŸ‡αž”αž‰αŸ’αž‡αžΈαž“αŸ… αž’αžΆαž˜αŸαžšαž·αž€
αž”αž·αž‘αž–αžΈαž˜αž»αž“
31.12$
αž…αž“αŸ’αž›αŸ„αŸ‡αž˜αž½αž™αž†αŸ’αž“αžΆαŸ†αž…αž»αž„αž€αŸ’αžšαŸ„αž™
24.95$ - 32.13$
αžŠαžΎαž˜β€‹αž‘αž»αž“β€‹αž‘αžΈαž•αŸ’αžŸαžΆαžš
55.30Β αž”αŸŠαžΈαž›αžΆαž“ USD
αž‘αŸ†αž αŸ†αž‡αž½αž‰αžŠαžΌαžšαž˜αž’αŸ’αž™αž˜
43.74Β αž–αžΆαž“αŸ‹
αž’αž“αž»αž”αžΆαž P/E
-
αž‘αž·αž“αŸ’αž“αž•αž›β€‹αž—αžΆαž‚αž›αžΆαž—
-
αž€αžΆαžšαžŠαŸ„αŸ‡αžŠαžΌαžšαž…αž˜αŸ’αž”αž„
TYO
αž€αŸ’αž“αž»αž„β€‹αž–αŸαžαŸŒαž˜αžΆαž“β€‹
αž αž·αžšαž‰αŸ’αž‰αžœαžαŸ’αžαž»
αžšαž”αžΆαž™αž€αžΆαžšαžŽαŸαž”αŸ’αžšαžΆαž€αŸ‹αž…αŸ†αžŽαžΌαž›
αž…αŸ†αžŽαžΌαž›
αž…αŸ†αžŽαžΌαž›αžŸαž»αž‘αŸ’αž’
(JPY)αž’αŸ’αž“αžΌ 2025αž€αžΆαžšαž•αŸ’αž›αžΆαžŸαŸ‹αž”αŸ’αžŠαžΌαžšαžαžΆαž˜β€‹αž†αŸ’αž“αžΆαŸ†
αž…αŸ†αžŽαžΌαž›
1.19Β αž‘αŸ’αžšαžΈαž›αžΆαž“4.16%
αž…αŸ†αžŽαžΆαž™αž”αŸ’αžšαžαž·αž”αžαŸ’αžαž·αž€αžΆαžš
661.30Β αž”αŸŠαžΈαž›αžΆαž“-7.52%
αž…αŸ†αžŽαžΌαž›αžŸαž»αž‘αŸ’αž’
103.64Β αž”αŸŠαžΈαž›αžΆαž“335.66%
αž”αŸ’αžšαžΆαž€αŸ‹αž…αŸ†αžŽαŸαž‰αžŸαž»αž‘αŸ’αž’
8.70318.27%
β€‹αž…αŸ†αžŽαžΌαž›αžŸαž»αž‘αŸ’αž’β€‹αž€αŸ’αž“αž»αž„αž˜αž½αž™αž—αžΆαž‚αž αŸŠαž»αž“
β€”β€”
αž…αŸ†αžŽαžΌαž›αžŸαž»αž‘αŸ’αž’αž˜αž»αž“αž€αžΆαžšαž”αŸ’αžšαžΆαž€αŸ‹ αž–αž“αŸ’αž’ αž€αžΆαžšαžšαŸ†αž›αžŸαŸ‹ αž“αž·αž„αž€αžΆαžšαž€αžΆαžαŸ‹αžšαŸ†αž›αžŸαŸ‹
182.70Β αž”αŸŠαžΈαž›αžΆαž“-8.24%
αž’αžαŸ’αžšαžΆαž–αž“αŸ’αž’αžŠαŸ‚αž›αž˜αžΆαž“αž”αŸ’αžšαžŸαž·αž‘αŸ’αž’αž—αžΆαž–
22.51%β€”
αž‘αŸ’αžšαž–αŸ’αž™αžŸαžšαž»αž”
αž€αžΆαžšαž‘αž‘αž½αž›αžαž»αžŸαžαŸ’αžšαžΌαžœαžŸαžšαž»αž”
(JPY)αž’αŸ’αž“αžΌ 2025αž€αžΆαžšαž•αŸ’αž›αžΆαžŸαŸ‹αž”αŸ’αžŠαžΌαžšαžαžΆαž˜β€‹αž†αŸ’αž“αžΆαŸ†
αžŸαžΆαž…αŸ‹αž”αŸ’αžšαžΆαž€αŸ‹ αž“αž·αž„αž€αžΆαžšαžœαž·αž“αž·αž™αŸ„αž‚αžšαž™αŸˆαž–αŸαž›αžαŸ’αž›αžΈ
654.94Β αž”αŸŠαžΈαž›αžΆαž“32.54%
αž‘αŸ’αžšαž–αŸ’αž™αžŸαžšαž»αž”
15.41Β αž‘αŸ’αžšαžΈαž›αžΆαž“2.00%
αž€αžΆαžšαž‘αž‘αž½αž›αžαž»αžŸαžαŸ’αžšαžΌαžœαžŸαžšαž»αž”
7.76Β αž‘αŸ’αžšαžΈαž›αžΆαž“1.00%
αž˜αžΌαž›β€‹αž’αž“αžŸαžšαž»αž”
7.64Β αž‘αŸ’αžšαžΈαž›αžΆαž“β€”
αž—αžΆαž‚αž αŸŠαž»αž“β€‹αž˜αž·αž“β€‹αž‘αžΆαž“αŸ‹αž”αžΆαž“αž”αž„αŸ‹
1.58Β αž”αŸŠαžΈαž›αžΆαž“β€”
αžαž˜αŸ’αž›αŸƒαž’αŸ€αž”αž“αžΉαž„αžŸαŸ€αžœαž—αŸ…
0.01β€”
αž•αž›αž…αŸ†αžŽαŸαž‰αž›αžΎαž‘αŸ’αžšαž–αŸ’αž™
2.16%β€”
αž•αž›αž…αŸ†αžŽαŸαž‰αž›αžΎαžŠαžΎαž˜αž‘αž»αž“
2.55%β€”
αž€αžΆαžšαž”αŸ’αžšαŸ‚αž”αŸ’αžšαž½αž›β€‹αžŸαžΆαž…αŸ‹αž”αŸ’αžšαžΆαž€αŸ‹αžŸαž»αž‘αŸ’αž’
(JPY)αž’αŸ’αž“αžΌ 2025αž€αžΆαžšαž•αŸ’αž›αžΆαžŸαŸ‹αž”αŸ’αžŠαžΌαžšαžαžΆαž˜β€‹αž†αŸ’αž“αžΆαŸ†
αž…αŸ†αžŽαžΌαž›αžŸαž»αž‘αŸ’αž’
103.64Β αž”αŸŠαžΈαž›αžΆαž“335.66%
αžŸαžΆαž…αŸ‹αž”αŸ’αžšαžΆαž€αŸ‹αž–αžΈαž”αŸ’αžšαžαž·αž”αžαŸ’αžαž·αž€αžΆαžš
373.25Β αž”αŸŠαžΈαž›αžΆαž“-2.74%
αžŸαžΆαž…αŸ‹αž”αŸ’αžšαžΆαž€αŸ‹αž–αžΈαž€αžΆαžšαžœαž·αž“αž·αž™αŸ„αž‚
-229.80Β αž”αŸŠαžΈαž›αžΆαž“-98.86%
αžŸαžΆαž…αŸ‹αž”αŸ’αžšαžΆαž€αŸ‹αž–αžΈαž αž·αžšαž‰αŸ’αž‰β€‹αž”αŸ’αž”αž‘αžΆαž“
-192.45Β αž”αŸŠαžΈαž›αžΆαž“70.66%
αž€αžΆαžšαž”αŸ’αžšαŸ‚αž”αŸ’αžšαž½αž›β€‹αžŸαžΆαž…αŸ‹αž”αŸ’αžšαžΆαž€αŸ‹αžŸαž»αž‘αŸ’αž’
-26.55Β αž”αŸŠαžΈαž›αžΆαž“92.72%
αž›αŸ†αž αžΌαžšαžŸαžΆαž…αŸ‹αž”αŸ’αžšαžΆαž€αŸ‹αž‘αŸ†αž“αŸαžš
28.34Β αž”αŸŠαžΈαž›αžΆαž“-90.09%
αž’αŸ†αž–αžΈ
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. Wikipedia
αž”αžΆαž“αž”αž„αŸ’αž€αžΎαžαž‘αžΎαž„
12 αž˜αž·αžαž»αž“αžΆ 1781
αžαŸ†αž”αž“αŸ‹β€‹αž”αžŽαŸ’αžŠαžΆαž‰
αž”αž»αž‚αŸ’αž‚αž›αž·αž€
47,455
αžŸαŸ’αžœαŸ‚αž„αžšαž€β€‹αž…αŸ’αžšαžΎαž“αž‘αŸ€αž
αž’αŸ’αž“αž€αž’αžΆαž…αž…αžΆαž”αŸ‹αž’αžΆαžšαž˜αŸ’αž˜αžŽαŸαž›αžΎ
αž”αž‰αŸ’αž‡αžΈαž“αŸαŸ‡αžαŸ’αžšαžΌαžœαž”αžΆαž“αž”αž„αŸ’αž€αžΎαžαž‘αžΎαž„αž–αžΈαž€αžΆαžšαžŸαŸ’αžœαŸ‚αž„αžšαž€αžαŸ’αž˜αžΈαŸ— αž˜αžΌαž›αž”αžαŸ’αžšαžŠαŸ‚αž›αž”αžΆαž“αžαžΆαž˜αžŠαžΆαž“ αž“αž·αž„αžŸαž€αž˜αŸ’αž˜αž—αžΆαž–αž•αŸ’αžŸαŸαž„αž‘αŸ€αžαŸ” αžŸαŸ’αžœαŸ‚αž„αž™αž›αŸ‹αž”αž“αŸ’αžαŸ‚αž˜

αž‘αž·αž“αŸ’αž“αž“αŸαž™ αž“αž·αž„αž–αŸαžαŸŒαž˜αžΆαž“αž‘αžΆαŸ†αž„αž’αžŸαŸ‹αžαŸ’αžšαžΌαžœαž”αžΆαž“αž•αŸ’αžαž›αŸ‹αž‡αžΌαž“ β€œαžŠαžΌαž…αžŠαŸ‚αž›αž˜αžΆαž“β€ αžŸαž˜αŸ’αžšαžΆαž”αŸ‹αžαŸ‚αž‚αŸ„αž›αž”αŸ†αžŽαž„αž–αŸαžαŸŒαž˜αžΆαž“αž•αŸ’αž‘αžΆαž›αŸ‹αžαŸ’αž›αž½αž“αž”αŸ‰αž»αžŽαŸ’αžŽαŸ„αŸ‡ αž αžΎαž™αž˜αž·αž“αž˜αžΆαž“αž‚αŸ„αž›αž”αŸ†αžŽαž„αž•αŸ’αžŠαž›αŸ‹β€‹αž‡αžΆαžŠαŸ†αž”αžΌαž“αŸ’αž˜αžΆαž“αž•αŸ’αž“αŸ‚αž€αž αž·αžšαž‰αŸ’αž‰αžœαžαŸ’αžαž» αž¬αž€αŸαžŸαž˜αŸ’αžšαžΆαž”αŸ‹αž‚αŸ„αž›αž”αŸ†αžŽαž„αž–αžΆαžŽαž·αž‡αŸ’αž‡αž€αž˜αŸ’αž˜αž¬αž€αžΆαžšαžœαž·αž“αž·αž™αŸ„αž‚ αž–αž“αŸ’αž’ αž…αŸ’αž”αžΆαž”αŸ‹ αž‚αžŽαž“αŸαž™αŸ’αž™ αž¬αžŠαŸ†αž”αžΌαž“αŸ’αž˜αžΆαž“αž•αŸ’αžŸαŸαž„αž‘αŸ€αžαž‘αžΎαž™αŸ” Google αž˜αž·αž“αž˜αŸ‚αž“αž‡αžΆαž‘αžΈαž”αŸ’αžšαžΉαž€αŸ’αžŸαžΆαž•αŸ’αž“αŸ‚αž€αžœαž·αž“αž·αž™αŸ„αž‚ αž¬αž‘αžΈαž”αŸ’αžšαžΉαž€αŸ’αžŸαžΆαž•αŸ’αž“αŸ‚αž€αž αž·αžšαž‰αŸ’αž‰αžœαžαŸ’αžαž»αž‘αŸ αž“αž·αž„αž˜αž·αž“αž”αž‰αŸ’αž…αŸαž‰αž‘αžŸαŸ’αžŸαž“αŸˆ αž€αžΆαžšαžŽαŸ‚αž“αžΆαŸ† αž¬αž‚αŸ†αž“αž·αžαž™αŸ„αž”αž›αŸ‹αž–αžΆαž€αŸ‹αž–αŸαž“αŸ’αž’αž“αžΉαž„αž€αŸ’αžšαž»αž˜αž αŸŠαž»αž“αžŽαžΆαž˜αž½αž™αžŠαŸ‚αž›αž˜αžΆαž“αž€αŸ’αž“αž»αž„αž”αž‰αŸ’αž‡αžΈαž“αŸαŸ‡ αž¬αž˜αžΌαž›αž”αžαŸ’αžšαžŽαžΆαž˜αž½αž™αžŠαŸ‚αž›αž…αŸαž‰αžŠαŸ„αž™αž€αŸ’αžšαž»αž˜αž αŸŠαž»αž“αž‘αžΆαŸ†αž„αž“αŸ„αŸ‡αžŠαŸ‚αžšαŸ” αžŸαžΌαž˜αž–αž·αž‚αŸ’αžšαŸ„αŸ‡αž‡αžΆαž˜αž½αž™αžˆαŸ’αž˜αž½αž‰αž€αžŽαŸ’αžαžΆαž› αž¬αžαŸ†αžŽαžΆαž„αž•αŸ’αž“αŸ‚αž€αž αž·αžšαž‰αŸ’αž‰αžœαžαŸ’αžαž»αžšαž”αžŸαŸ‹αž’αŸ’αž“αž€ αžŠαžΎαž˜αŸ’αž”αžΈαž•αŸ’αž‘αŸ€αž„αž•αŸ’αž‘αžΆαžαŸ‹αžαž˜αŸ’αž›αŸƒαž˜αž»αž“αž“αžΉαž„αž”αŸ’αžšαžαž·αž”αžαŸ’αžαž·αž€αžΆαžšαž‡αž½αž‰αžŠαžΌαžšαžŽαžΆαž˜αž½αž™αŸ” αžŸαŸ’αžœαŸ‚αž„αž™αž›αŸ‹αž”αž“αŸ’αžαŸ‚αž˜
αž€αŸαž˜αžΆαž“β€‹αž’αŸ’αž“αž€β€‹αžŸαŸ’αžœαŸ‚αž„αžšαž€β€‹αžŠαŸ‚αžš
αžŸαŸ’αžœαŸ‚αž„αžšαž€
αžŸαž˜αŸ’αž’αžΆαžβ€‹αž€αžΆαžšβ€‹αžŸαŸ’αžœαŸ‚αž„αžšαž€
αž”αž·αž‘β€‹αž€αžΆαžšβ€‹αžŸαŸ’αžœαŸ‚αž„αžšαž€
αž€αž˜αŸ’αž˜αžœαž·αž’αžΈ Google
αž˜αŸ‰αžΊαž“αž»αž™αžŠαžΎαž˜